Litcius/Paper detail

Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39−CD73 signaling pathway

Junlong Dang, Zhenjian Xu, Anping Xu, Yan Liu, Qing‐Ling Fu, Julie Wang, Feng Huang, Yuejuan Zheng, Guangying Qi, Boqing Sun, Joseph A. Bellanti, Umadevi Kandalam, Hany A. Emam, Wael N. Jarjour, Song Guo Zheng

2020Journal of Autoimmunity42 citationsDOI

Topics & Concepts

Mesenchymal stem cellLupus nephritisImmunologySystemic lupus erythematosusMedicineAdoptive cell transferAutoantibodyCell therapyAutoimmunityImmune systemStem cellCancer researchT cellBiologyCell biologyPathologyAntibodyDiseaseImmune Cell Function and InteractionAdenosine and Purinergic SignalingImmune cells in cancer
Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39−CD73 signaling pathway | Litcius